Nearly twice as many cases involving long-term symptoms after COVID-19 Three months after infection with the coronavirus SARS-CoV-2, almost half of people still report one or more long-term symptoms, such as fatigue, difficulty concentrating and loss of smell.
New test for Lyme disease is not reliable To determine whether someone has Lyme disease, doctors in the Netherlands often use antibody tests. For some time now, so-called cellular tests have been available on the market.
Many more infections, limited increase in hospital admissions In the past week, the number of people who tested positive for COVID-19 in the Netherlands increased by 64% compared to the week before that.
First clients and care workers in mental healthcare vaccinated on Monday The first mental health clients in inpatient or residential care in four large institutions in the Netherlands will be vaccinated against COVID-19 this week.
New research in GGD test lanes on spread of coronavirus SARS-CoV-2 RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.
New variants disrupt plans In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.
One person died shortly after COVID-19 vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.
Nationwide assessment of SARS-CoV-2 laboratories: very high quality The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.
PhD dissertation: Dutch Q fever epidemic in 'One Health' context Today Barbara Schimmer will be defending her PhD dissertation entitled The Q fever epidemic in the Netherlands in a One Health context, at Utrecht University.